Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
CNB Financial | CCNE | 5. nov 2024 | 25.84 | +1.33 |
CNB Financial Pref | CCNEP | 5. nov 2024 | 24.49 | -0.85 |
CNFinance ADR | CNF | 5. nov 2024 | 1.07 | +0.94 |
CNH Industrial N.V. | CNH | 5. nov 2024 | 11.25 | +0.63 |
CNO Financial Group | CNO | 5. nov 2024 | 35.83 | +0.22 |
CNS Pharmaceuticals | CNSP | 5. nov 2024 | 0.11 | +3.45 |
CNX Resources | CNX | 5. nov 2024 | 35.36 | +1.90 |
Co-Diagnostics | CODX | 5. nov 2024 | 1.21 | -0.82 |
Coastal Financial | CCB | 5. nov 2024 | 63.91 | +1.74 |
Coca-Cola | KO | 5. nov 2024 | 65.37 | +0.40 |
Coca-Cola Consolidated | COKE | 5. nov 2024 | 1 179.62 | +3.15 |
Coca-Cola Europacific Partners | CCEP | 5. nov 2024 | 77.84 | +2.62 |
Coca-Cola FEMSA ADR | KOF | 5. nov 2024 | 81.33 | +0.94 |
Cocrystal Pharma | COCP | 5. nov 2024 | 1.80 | -3.22 |
Coda Octopus | CODA | 5. nov 2024 | 8.61 | -1.03 |
Codere Online Luxembourg | CDRO | 5. nov 2024 | 7.54 | -1.57 |
Codexis | CDXS | 5. nov 2024 | 3.82 | +9.46 |
Coeptis Therapeutics | COEP | 5. nov 2024 | 0.20 | +0.50 |
Coeur Mining | CDE | 5. nov 2024 | 6.07 | +0.83 |
Coffee Holding Company | JVA | 5. nov 2024 | 2.97 | +1.37 |
Cogent Biosciences | COGT | 5. nov 2024 | 9.99 | -15.84 |
Cogent Communications | CCOI | 5. nov 2024 | 81.58 | +0.18 |
Cognex | CGNX | 5. nov 2024 | 39.84 | -2.47 |
Cognition Therapeutics | CGTX | 5. nov 2024 | 0.49 | +2.91 |
Cognizant Technology Solutions A | CTSH | 5. nov 2024 | 75.39 | +0.65 |
Cognyte Software | CGNT | 5. nov 2024 | 6.74 | +4.01 |
Cohen & Company | COHN | 5. nov 2024 | 9.89 | -0.40 |
Cohen & Steers | CNS | 5. nov 2024 | 101.13 | +3.24 |
Cohen & Steers Closedend Opportunity Fund | FOF | 5. nov 2024 | 12.68 | +0.24 |
Cohen & Steers Duration Pref and Income Fund | LDP | 5. nov 2024 | 20.97 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.